Randomized Control Study of Nedaplatin or Cisplatin Concomitant with Other Chemotherapy in the Treatment of Advanced Non-small Cell Lung Cancer |
Li, Chun-Hong
(Department of Internal Medical Oncology, Harbin Medical University Cancer Hospital)
Liu, Mei-Yan (Department of Internal Medical Oncology, Harbin Medical University Cancer Hospital) Liu, Wei (Department of Internal Medical Oncology, Harbin Medical University Cancer Hospital) Li, Dan-Dan (Department of Internal Medical Oncology, Harbin Medical University Cancer Hospital) Cai, Li (Department of Internal Medical Oncology, Harbin Medical University Cancer Hospital) |
1 | Wagner TD, Yang GY (2006). The role of chemotherapy and radiation in the treatment of Belvedere O, Grossi F. Lung Cancer Highlights from ASCO 2005. Oncologist, 11, 39-50. DOI ScienceOn |
2 | Terret C, Albrand G, Moncenix G, et al (2011). Karnofsky Performance Scale (KPS) or Physical Performance Test (PPD? That is the question. Crit Rev Oncol Hematol, 77, 142-7. DOI ScienceOn |
3 | Wagner TD, Yang GY (2010). The role of chemotherapy and radiation in the treatment of locally advanced non-small cell lung cancer (NSCLC). Curt Drug Targets, 1l, 67-73. DOI ScienceOn |
4 | Yu DP, Han Y, Zhao QY, et al (2012). Pulmonary lobectomy combined with pulmonary arterioplasty by complete videoassisted thoracic surgery in patients with lung cancer. Asian Pac J Cancer Prev, 14, 6061-4. 과학기술학회마을 DOI ScienceOn |
5 | Oven Ustaalioglu BB, Unal OU, Turan N, et al (2013). Prognostic factors for lymph node negative stage I and IIA non-small cell lung cancer, multicenter experiences. Asian Pac J Cancer Prev, 14, 6287-92. 과학기술학회마을 DOI ScienceOn |
6 | Maione P, Rossi A, Bareschino MA, et al (2011). Factors driving the choice of the best second-line treatment of advanced NSCLC. Rev Recent Clin Trials, 6, 44-51. DOI |
7 | Mandal SK, Singh TT, Sharma TD, et al (2013). Clinicopathology of lung cancer in a regional cancer center in Northeastern India. Asian Pac J Cancer Prev, 14, 7277-81. DOI ScienceOn |
8 | Niioka Z Uno Z Yasui-Furukori N, et al (2007). Pharmacokinetics of lowdose nedaplatin and validation of AUC prediction in patients with non-small cell lung carcinoma. Cancer Chemother Pharmacol, 59, 575-80. DOI ScienceOn |
9 | Rinaldi M, Cauchi C, Gridelli C, et al (2006). First line chemotherapy in advanced or metastatic NSCLC. Ann OncoL, 17, V64-7. DOI ScienceOn |
10 | Sugiyama T, Hirose T, Nakashima M (2011). Evaluation of the efficacy and safety of the combination of gemcitabine and nedaplatin for elderly patients with advanced non-small cell lung cancer. Oncology, 81, 273-80. DOI ScienceOn |
11 | Scagliotti GV, Parikh P'yon Pawel J, et al (2008). Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advancedstage non-small-cell lung cancer. J Clin Oncol, 26, 3543-51. DOI ScienceOn |
12 | Hotta K, Matsuo K, Ueoka H, et al (2004). Meta-analysis of randomized clinical trials comparing Cisplatin to Carboplain in patients with advanced non-small-cell lung cancer. J Clin Oncol, 22, 3852-9. DOI ScienceOn |
13 | Jin-ji Yang, Qing Zhou, Ri-qiang Liao, et al (2012). Nedaplatin/Gemcitabine Versus Carboplatin/Gemcitabine in Treatment of Advanced Non-small Cell Lung Cancer, A Randomized Clinical Trial. Chin J Cancer Res, 24, 97-102. DOI ScienceOn |
14 | Arriagada R, Bergman B, Dunant A, et al (2004). Cisplatin_based adjuvant chemotherapy in patients with completely resected non-small cell lung cancer. N Engl J Med, 350, 351-60. DOI ScienceOn |
15 | Govindan R, Page N, Morgensztern D, et al (2006). Changing epidemiology of small-cell lung cancer in the United States over the last 30 years, analysis of the surveillance, epidemiologic, and end results database. J Clin Oncol, 24, 4539-44. DOI ScienceOn |
16 | Jemal A, Siegel R, Ward E, et al (2008). Cancer statistis, 2008. CA Cancer J Clin, 58, 71-96. DOI ScienceOn |
17 | Kameyama Y, Okazaki N, Nakagawa M, et al (1990). Nephrotoxicity of a new platinum compound, 254-S, evaluated with rat kidney cortical slices. Toxicol Lett, 52, 15-24. DOI ScienceOn |
18 | Kim JL, Cho KH, Park EC, et al (2014). A single measure of cancer burden combining incidence with mortality rates for worldwide application. Asian Pac J Cancer Prev, 15, 433-9. 과학기술학회마을 DOI ScienceOn |
19 | Liu J, Li N, Chang S, et al (2013). Characteristics of 240 Chinese father-child pairs with malignant disease. Asian Pac J Cancer Prev, 14, 6501-5. 과학기술학회마을 DOI ScienceOn |
20 | Teramoto K, AsadaY, Ozaki Y, et al (2012). A phase II study of docetaxel plus nedaplatin in patients with metastatic nonsmall-cell lung cancer. Cancer Chemother Pharmacol, 70, 531-7. DOI ScienceOn |
21 | Alberto ME, Lucas MF, Pavelka M, et al (2009). The secondgeneration anticancer drug Nedaplatin, atheoretical investigation on the hydrolysis mechanism. J Phys Chen B, 113, 14473-9. DOI ScienceOn |